https://www.zacks.com/stock/news/2265255/pbh-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2265255
Apr 30, 2024 - PBH vs. ABT: Which Stock Is the Better Value Option?
zc:3865968347356327738
0
https://www.fool.com/earnings/call-transcripts/2024/04/17/abbott-laboratories-abt-q1-2024-earnings-call-tran/?source=iedfolrf0000001
Apr 17, 2024 - ABT earnings call for the period ending March 31, 2024.
0
fool:-5307293686797978391
0
https://www.zacks.com/stock/news/2256957/abbott-abt-q1-earnings-beat-estimates-margins-contract?cid=CS-ZC-FT-analyst_blog|earnings_article-2256957
Apr 17, 2024 - Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
zc:3308612154215796352
0
https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?source=feed_sector_healthcare
Apr 17, 2024 - Eli Lilly (LLY), Abbott Laboratories (ABT), Travelers (TRV), Capri (CPRI) and Tapestry (TPR) are the stocks to watch on Wednesday.
0
sa:7838279641281620799
0
https://www.zacks.com/stock/news/2254571/what-s-in-store-for-abbott-laboratories-abt-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254571
Apr 12, 2024 - Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
zc:-5876254083692607607
0
https://www.zacks.com/stock/news/2252958/abbott-abt-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2252958
Apr 09, 2024 - The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.
zc:-3162060159274947691
0
https://www.zacks.com/stock/news/2252781/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2252781
Apr 09, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
zc:-4173384343437374902
0
https://www.zacks.com/stock/news/2251992/abbott-abt-faces-low-testing-demand-currency-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2251992
Apr 08, 2024 - Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
zc:8036270438900298026
0
https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993
Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
zc:-7773365123072611994
0
https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046
Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
zc:-7039653779049094100
0